PURPOSE: Although positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18 F-FDG) has a major impact on the treatment of adult cancer, the reported experience with extracranial ...
Physician-reported barriers and strategies to using tumor mutational burden (TMB) testing in oncology care: An interview based study. From seed to harvest: 18-month experience of molecular tumor board ...
This retrospective study compared I-123-MIBG scintigraphy with FDG PET in 60 patients with neuroblastoma (113 paired studies performed within 2 weeks of each other). FDG PET was found to be more ...
Accurate staging for a patient with neuroblastoma is essential. It has implications for prognosis and guides the treatment required for individuals with the disease. In 2009, the INRG project ...
High-dose 131I-mIBG therapy is a critical treatment option for high-risk neuroblastoma, a common solid tumors in children, especially when conventional therapies fail.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 8, 2006--Molecular Insight Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Ultratrace ...
After nine months of treatment, four-year-old Leah Still got some great news on Tuesday night: Her MIBG scan came back negative, which means doctors didn't seen any active disease in her body. An MIBG ...
The treatment uses a radioactive form of iodine called iodine 131. The radioactive iodine circulates through your body in the bloodstream. The tumour cells pick up the radioactive iodine wherever they ...
For patients with NB resistant to a wide range of agents, and ineligible for clinical trials, we have used a 5-day/5-drug (5D/5D) regimen consisting of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results